Advancing Health Equity and Preventive Cardiovascular Care in Indigenous and Remote Communities: a Mobile Healthcare Unit

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-65
SponsorLaval University

About this trial

Indigenous people living in Canada face significant healthcare inequities, particularly in basic, primary, and secondary prevention, leading to higher rates of cardiovascular disease and mortality. This program aims to develop a comprehensive understanding of the contextual and individual determinants influencing Indigenous health, and to address health disparities by using tailored community-led participatory research and care initiatives. The investigator and research team use a Mobile Healthcare Unit travelling to Indigenous communities, providing customized, impactful, and sustainable preventive care that adapts dynamically to the evolving needs of each community. The initiative places a strong emphasis on equity and inclusivity, aiming to generate original data in Indigenous and remote underrepresented/underserved populations. This proposal will improve opportunities of identifying facilitators and barriers to preventive care in Indigenous and remote communities. This focus is vital for reducing health disparities and aligns with the Truth and Reconciliation Calls to Action. To maximize knowledge mobilization and ensure culturally appropriate initiatives align with community needs and priorities, this research program collaborates with the Indigenous University Hub at Laval University, local community members and leaders, and Indigenous peoples with lived experience. Existing national and international collaborations with Indigenous communities further enhance the initiative's potential impact and foster knowledge mobilization on a global scale. The ultimate goal is to empower Indigenous peoples and communities to advocate for systemic changes to fight inequities in healthcare in accordance with appropriated truth and reconciliation efforts.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

BMI > 27 kg/m²

Disqualifiers

Being pregnant;

Known heart condition

Trial design

Design model

Single group

Treatments tested in this trial

  • Cardiovascular risk screening

    Other intervention

    Extensive cardiovascular risk screening offered locally in underserved/ underrepresented communities (see Study Description for more details)

  • Follow-up of cardiovascular risk factors

    Other intervention

    Measure changes in cardiovascular risk factors among participants who took place in the screening phase.

Treatment groups

500 Participants
are divided into 1 treatment group
Group A: Preventive careOther 2 interventions

Trial outcomes

Primary outcomes

1

Height in meters

Measured using a stadiometer

Time frame
Once, at baseline.
2

Weight in kilograms

Measured using an electronic body scale

Time frame
At baseline and at 1 year
3

Body mass index in kg/(m^2)

BMI will be calculated by dividing the weight in kilograms by the square of the height in meters

Time frame
At baseline and at 1 year
4

Waist circumference in centimeters

Waist circumference will be measured using an ergonomic circumference measuring tape

Time frame
At baseline and at 1 year

Secondary outcomes

1

Participant feedback on intervention

Questionnaire on participant satisfaction and areas of improvement in health equity.

Time frame
At baseline and at one-year follow-up

Other outcomes

1

Body fat distribution

Percentage and kilograms, using a electrical bioimpedance device

Time frame
At baseline
2

Liver fat content

Measured with liver elastography

Time frame
At baseline
3

Arterial stiffness

Measured by pulse wave velocity

Time frame
At baseline

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Laval University

Lead sponsor

Canadian Institutes of Health Research (CIHR)

Collaborator